PRESS RELEASE published on 05/14/2025 at 07:30, 10 months 2 days ago Nicox Announces Results of the Exploratory Whistler Phase 3b Glaucoma Trial Nicox announces positive results of Whistler Phase 3b glaucoma trial with NCX 470 showing efficacy in lowering intraocular pressure via dual mechanism action of nitric oxide and prostaglandin analogs. Safety profile consistent with previous trial Nicox NCX 470 Glaucoma Trial Whistler Phase 3b Intraocular Pressure
BRIEF published on 04/30/2025 at 07:35, 10 months 16 days ago Nicox Reports Full Year 2024 Financials Net Loss Cash Reserves Nicox Financial Results VYZULTA Revenue Sale NCX 470 Trials
PRESS RELEASE published on 04/30/2025 at 07:30, 10 months 16 days ago Nicox Provides Full Year 2024 Financial Results Nicox reports €7.9 million revenue for 2024 with exceptional income of €13.7 million from VYZULTA transfer. Cash of €10.5 million and NCX 470 Phase 3 trial results expected in Q3 2025 Financial Results Revenue Nicox NCX 470 VYZULTA
BRIEF published on 03/19/2025 at 07:35, 11 months 28 days ago Nicox Completes Final Visit for NCX 470 Phase 3b Whistler Glaucoma Trial Glaucoma Nicox Clinical Results NCX 470 Phase 3b Trial
PRESS RELEASE published on 03/19/2025 at 07:30, 11 months 28 days ago Nicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma Trial Nicox completes final patient visits in Phase 3b Whistler Glaucoma Trial for NCX 470, with results expected May 2025. Denali trial in progress, results planned for Q3 2025 Clinical Development Nicox NCX 470 Phase 3b Glaucoma Trial
BRIEF published on 01/28/2025 at 07:35, 1 year 1 month ago Nicox: Participation in Major Congresses in 2025 Investment Ophthalmology Congress Nicox NCX 470
PRESS RELEASE published on 01/28/2025 at 07:30, 1 year 1 month ago Nicox Announces Scientific Presentation and Conference Attendance in H1 2025 Nicox to present at AGS 2025 Annual Meeting and attend key ophthalmology and financial conferences in H1 2025. Dr. Robert Fechtner to present NCX 470 analysis at AGS 2025 Conference Ophthalmology Nicox NCX 470 AGS 2025
BRIEF published on 01/22/2025 at 07:35, 1 year 1 month ago Nicox maintains its eligibility for the PEA-PME PEA-PME Euronext Investment Ophthalmology Nicox
BRIEF published on 01/21/2025 at 07:35, 1 year 1 month ago Nicox: Fourth Quarter 2024 Financial and Business Summary Financial Results Treasury Nicox NCX 470 Fourth Quarter 2024
PRESS RELEASE published on 01/21/2025 at 07:30, 1 year 1 month ago Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights Nicox provides Q4 2024 financial highlights, including €13.7 million revenue and €10.7 million cash. Final patient enrolled in NCX 470 trial, with results expected in Q3 2025 Financial Highlights Nicox Q4 2024 Q3 2025 NCX 470 Trial
Published on 03/16/2026 at 11:30, 1 minute ago Relevant Gold Announces $15 Million Strategic Financing with Participation from Kinross, Bollinger, and McEwen
Published on 03/16/2026 at 11:00, 31 minutes ago Vox Royalty Announces Inclusion in MVIS(R) Global Junior Gold Miners Index and VanEck Junior Gold Miners ETF (GDXJ)
Published on 03/16/2026 at 11:00, 31 minutes ago Banyan Intercepts Several New Distinct High-grade Silver Veins, including 3,408 g/t Ag over 1.4 m, at AurMac, Yukon
Published on 03/15/2026 at 23:25, 12 hours 6 minutes ago Tunkillia 'Phase 2' Resource Upgrade Drilling Begins
Published on 03/15/2026 at 18:00, 17 hours 31 minutes ago SEG Announced 2025 Annual Results Initiating First Special Dividend Distribution Payout Ratio Reached 88% Newly Signed Orders Exceeded RMB100-Billion Mark for the Second Consecutive Year
Published on 03/16/2026 at 11:00, 31 minutes ago BIO-Europe Spring® 2026: Partnering Momentum Builds as Global Biopharma Leaders Set Course for Lisbon
Published on 03/16/2026 at 11:00, 31 minutes ago CTS EVENTIM: EVENTIM LIVE expands in the French live market with promoter Pierre-Alexandre Vertadier
Published on 03/16/2026 at 11:00, 31 minutes ago Vossloh to deliver high-speed grinding train to China
Published on 03/16/2026 at 11:00, 31 minutes ago Nebius signs new AI infrastructure agreement with Meta
Published on 03/16/2026 at 10:45, 45 minutes ago HKTDC Smart Lighting Expo and Hong Kong International Lighting Fair (Spring Edition) to open in April
Published on 03/16/2026 at 08:30, 3 hours 1 minute ago CDA - Update on CDA' parks solarization program
Published on 03/13/2026 at 19:50, 2 days 15 hours ago Availability of ENGIE’S 2025 Universal Registration Document
Published on 03/13/2026 at 18:05, 2 days 17 hours ago Availability of the 2025 Universal Registration Document of OPmobility SE
Published on 03/13/2026 at 07:30, 3 days 4 hours ago BIOPHYTIS PRESENTS ITS DEVELOPMENT PROGRAMS IN OBESITY AND SARCOPENIA AT THE ICFSR CONFERENCE
Published on 03/12/2026 at 18:00, 3 days 17 hours ago NEW OR RENEWED AGREEMENTS BETWEEN EURAZEO AND CERTAIN FAMILY SHAREHOLDERS
